HomeGenetics UnderstandingConsultHow are genetic conditions treated or managed?
Back to Consult
How are genetic conditions treated or managed?
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Consult

How are genetic conditions treated or managed?

While most genetic disorders cannot be cured, various medical approaches are available to manage symptoms, prevent complications, and improve quality of life.

Overview

Many genetic disorders result from gene changes present in essentially every cell in the body. Because these disorders often affect multiple body systems, most cannot be cured. However, healthcare providers use a variety of strategies to treat or manage associated signs and symptoms.

Management Strategies

Inborn Errors of Metabolism

These conditions result from genetic changes that disrupt the production of specific enzymes. Management strategies include:

  • Dietary changes: Limiting certain substances in the diet to prevent the buildup of toxic compounds that the body cannot break down.
  • Enzyme replacement therapy: Providing the missing enzyme to make up for the shortage.

These treatments help manage existing symptoms and prevent future complications, as seen in conditions like phenylketonuria (PKU).

Symptom-Specific Treatments

For many other conditions, management is tailored to the individual's specific health needs:

  • Surgery: Used to repair physical defects, such as heart defects associated with genetic disorders.
  • Transplants: Procedures like heart transplants or bone marrow transplants (used for conditions like sickle cell disease) can address specific organ or blood cell formation issues.

Preventive Management

When genetic changes increase the risk of future health problems, such as certain forms of cancer, management may involve:

  • Frequent screening: Regular monitoring to detect issues early.
  • Prophylactic surgery: Preventive removal of tissues at high risk of becoming cancerous, such as in cases of familial breast cancer related to BRCA1 and BRCA2 mutations.

Supportive and Experimental Care

In cases where genetic disorders are severe or incompatible with life, health professionals provide supportive care, such as pain relief or mechanical breathing assistance. While most current strategies do not alter the underlying mutation, gene therapy—an experimental technique involving the modification of a person's genes—is currently being studied in clinical trials alongside other emerging treatment approaches.

Additional Resources

  • GeneReviews: Provides detailed, peer-reviewed information on the management of specific genetic disorders.
  • MedlinePlus: Offers further information on inborn errors of metabolism, bone marrow transplantation, palliative care, gene therapy, and precision medicine.
  • ClinicalTrials.gov: A service of the National Institutes of Health that allows users to search for ongoing clinical trials by condition, location, or treatment approach.

Frequently Asked Questions

Prophylactic surgery refers to the preventive removal of healthy tissue that has a high risk of developing cancer due to a known genetic mutation, such as BRCA1 or BRCA2. For example, a woman with a BRCA mutation might choose to have a mastectomy to reduce her risk of breast cancer. This is not a treatment for existing cancer but a risk-reduction strategy. Decisions about prophylactic surgery are complex and involve weighing the risks of surgery against the risk of developing cancer, often in consultation with a genetic counselor and surgeon.
Enzyme replacement therapy (ERT) involves administering the missing enzyme directly to the body to manage symptoms and prevent complications, such as in certain lysosomal storage disorders. It is a ongoing treatment that does not alter the underlying genetic defect. Gene therapy, on the other hand, aims to correct the root cause by introducing a functional copy of the gene into the patient's cells. While ERT is currently available for several conditions, gene therapy is still largely experimental or approved for a limited number of specific genetic diseases and is typically a one-time treatment.
Many genetic conditions are chronic but can be managed effectively in an outpatient setting with a coordinated care team. This team may include a primary care physician, a geneticist, and specialists for specific organ systems (such as cardiology or neurology). Management typically involves regular monitoring, medication, dietary adjustments, and physical therapy. Hospitalization is usually reserved for acute complications, surgeries, or when a condition requires intensive initial stabilization, but long-term management is often done at home with regular clinic visits.
For conditions like phenylketonuria (PKU), the body lacks the enzyme needed to break down the amino acid phenylalanine. If phenylalanine builds up, it can cause severe intellectual disability and other health issues. Management involves a strict lifelong diet that limits high-protein foods containing phenylalanine while ensuring adequate nutrition through special medical formulas. Regular blood tests are required to monitor phenylalanine levels and adjust the diet as needed to prevent toxicity.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss